Chandler C E, Miller L J
Metabolism. 1986 Apr;35(4 Suppl 1):71-7. doi: 10.1016/0026-0495(86)90191-5.
Sorbinil (CP 45,634), a potent aldose reductase (AR) inhibitor, has the ability to normalize both sorbitol levels and functional parameters such as orthograde axonal transport and motor nerve conduction velocity in peripheral nerves of diabetic rats, which implicates flux through the polyol pathway in the pathophysiology of diabetic neuropathy. In order to understand more fully the role of this enzyme, it is important to determine the major cellular location of AR in peripheral nerve. Experiments were designed that have taken advantage of the observation that peripheral nerve axons degenerate distal to an injury site, while Schwann cells remain viable. One sciatic nerve in each experimental rat was chronically ligated (up to 6 weeks) before inducing diabetes by an intravenous (iv) injection of streptozotocin (STZ; 65 mg/kg). Two days after the STZ injection, both sciatic nerves were removed from each animal, and the ligated nerve was divided into proximal (Schwann cells and axons) and distal (Schwann cells only) portions before being processed for sorbitol determinations. The intact nerves and the proximal portion of the ligated nerves (having both Schwann cells and axons) retained the ability to accumulate sorbitol after STZ injection, while the distal portion (having Schwann cells only) lost this capacity 4 days after ligation. This lack of ability to accumulate sorbitol was not due to failure of the substrate (glucose) to reach the distal nerve segment. Additionally, homogenates of whole nerves and of proximal portions of ligated nerves were able to form sorbitol from glucose in the presence of NADPH while homogenates of distal portions of ligated nerves had lost approximately 85% of this activity.(ABSTRACT TRUNCATED AT 250 WORDS)
索比尼尔(CP 45,634)是一种有效的醛糖还原酶(AR)抑制剂,它能够使糖尿病大鼠外周神经中的山梨醇水平以及诸如顺向轴突运输和运动神经传导速度等功能参数恢复正常,这表明多元醇途径的通量在糖尿病神经病变的病理生理学中起作用。为了更全面地了解这种酶的作用,确定AR在周围神经中的主要细胞定位很重要。所设计的实验利用了这样的观察结果:外周神经轴突在损伤部位远端会发生退化,而施万细胞仍保持存活。在通过静脉注射链脲佐菌素(STZ;65mg/kg)诱导糖尿病之前,对每只实验大鼠的一条坐骨神经进行慢性结扎(长达6周)。在注射STZ两天后,从每只动物身上取出两条坐骨神经,将结扎的神经分为近端(施万细胞和轴突)和远端(仅施万细胞)部分,然后进行山梨醇测定处理。完整的神经和结扎神经的近端部分(既有施万细胞又有轴突)在注射STZ后仍保留积累山梨醇的能力,而远端部分(仅施万细胞)在结扎4天后失去了这种能力。这种积累山梨醇能力的缺乏并非由于底物(葡萄糖)未能到达远端神经节段。此外,完整神经和结扎神经近端部分的匀浆在有NADPH存在的情况下能够从葡萄糖形成山梨醇,而结扎神经远端部分的匀浆则失去了大约85%的这种活性。(摘要截取自250字)